• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I TOTAL B-HCG REAGENT KIT; SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I TOTAL B-HCG REAGENT KIT; SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN Back to Search Results
Catalog Number 07P51-20
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/23/2023
Event Type  malfunction  
Manufacturer Narrative
This report is being filed on an international product, list number (b)(4), that has a similar product distributed in the us, list number (b)(4).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
 
Event Description
The customer stated that falsely decreased alinity i toal b-hcg results of <2.3 miu/ml were generated for a patient sample.The following data was provided.(b)(6).Initial result: < 2.3 miu/ml (negative).Retest result (same day): <2.3 miu/ml (negative).Retest the following day (as the patient report stated that a home test was weakly positive): 16.28 miu/ml (grayzone).The sample was sent to another laboratory for testing using the roche b-hcg method and the result was positive at 13.5 miu/ml.No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and in house testing of a retained reagent kit, lot 45177ud00.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.The ticket search by lot indicates that the complaint lot performs as expected for this product.Ticket trending review did not identify any trends.Device history review did not identify any non-conformances or deviations with the complaint lot.In-house testing was completed using panels which mimic patient samples using an in-house retained kit.All specifications were met, indicating the lot is performing acceptably.Labeling was reviewed and sufficiently addresses the customer¿s issue.Based on the investigation, no systemic issue or deficiency of the alinity i total b-hcg reagent lot 45177ud00 was identified.
 
Event Description
The customer stated that falsely decreased alinity i toal b-hcg results of <2.3 miu/ml were generated for a patient sample.The following data was provided.Sid (b)(6).Initial result: < 2.3 miu/ml (negative) retest result (same day): <2.3 miu/ml (negative) retest the following day (as the patient report stated that a home test was weakly positive): 16.28 miu/ml (grayzone).The sample was sent to another laboratory for testing using the roche b-hcg method and the result was positive at 13.5 miu/ml.No impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I TOTAL B-HCG REAGENT KIT
Type of Device
SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key17543478
MDR Text Key321144413
Report Number3005094123-2023-00215
Device Sequence Number1
Product Code DHA
Combination Product (y/n)N
Reporter Country CodeTC
PMA/PMN Number
K170317
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/14/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/05/2023
Device Catalogue Number07P51-20
Device Lot Number45177UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/01/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/06/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, (B)(6); ALNTY I PROCESSING MODU, 03R65-01, (B)(6)
Patient SexFemale
-
-